Problem Solving and Preventive Measures: Pharmacists’ Concern to Patient Care

International Journal of Pharmacy and Biomedical Engineering
© 2019 by SSRG - IJPBE Journal
Volume 6 Issue 1
Year of Publication : 2019
Authors : AK Mohiuddin
: 10.14445/23942576/IJPBE-V6I1P101
MLA Style:

AK Mohiuddin, "Problem Solving and Preventive Measures: Pharmacists’ Concern to Patient Care" SSRG International Journal of Pharmacy and Biomedical Engineering 6.1 (2019): 1-10.

APA Style:

AK Mohiuddin,(2019). Problem Solving and Preventive Measures: Pharmacists’ Concern to Patient Care. SSRG International Journal of Pharmacy and Biomedical Engineering 6(1), 1-10.


As important members of the health care team, pharmacists work collaboratively with patients’ other health care providers in all types of patient care settings ranging from community pharmacies to hospitals and long-term care facilities. Across these settings, pharmacists take specific actions that regularly contribute to improving patient safety. In addition to training on medications, pharmacist education and training includes assessing health status of patients, providing education and counselling, managing diseases, and using health care technologies. Pharmacists use this education and training to prevent medication errors, drug interactions, and other adverse medication events from reaching patients. With the expanding number and complexity of medications, pharmacists’ roles and responsibilities have expanded broadly beyond medication distribution. Pharmacists are providing patient care in almost all health care settings to help people of all ages get the most from the medications that are prescribed to them. Examples of pharmacists’ patient care services include providing health and wellness screenings, managing chronic diseases, assisting patients with medication management, administering immunizations, and working with hospitals and health systems to improve patient care and reduce the number of patients who are readmitted to the hospital following their hospital stay.


[1] Office of Disease Prevention and Health Promotion (ODPHP). 2020 Topics and Objectives – Objectives A–Z. URL:
[2] Vadher D, Cannon BC. Chapter 122. Development of a Pharmacy Care Plan and Patient Problem-Solving. In: Remington: The Science And Practice Of Pharmacy by Joseph P Remington; Paul Beringer , published by Philadelphia: Lippincott Williams & Wilkins, ©2006
[3] APhA. Principles of Practice for Pharmaceutical Care.
[4] Available From::
[5] Zaal RJ, Jansen MM and others. Identification of drug-related problems by a clinical pharmacist in addition to computerized alerts. Int J Clin Pharm. 2013 Oct;35(5):753-62. doi: 10.1007/s11096-013-9798-4. Epub 2013 May 29. PMID: 23715760
[6] Shields KM, Blythe E. Chapter 3. Drug Information Resources. Drug Information: A Guide for Pharmacists, 4e. Copyright © 2012 by McGraw-Hill Education, LLC.
[7] Smith M, Saunders R, Stuckhardt L. Chapter 7. Engaging Patients, Families, and Communities. Best Care at Lower Cost: The Path to Continuously Learning Health Care in America. Committee on the Learning Health Care System in America;
Institute of Medicine; Washington (DC): National Academies Press (US); 2013 May 10.
[8] Ibrahim OHM, Ibrahim RM. Community pharmacists’ involvement in breast cancer health promotion in United Arab Emirates (UAE). Am J Pharmacol Toxicol 2013;8(4):155-63.
[9] Odedin FT, Warrick C, Vilme H, Young S. Pharmacists as health educators and risk communicators in the early detection of prostate cancer. Res Soc Admin Pharm 2008;4(1): 59-66.
[10] Jordan MA and Harmon J. Pharmacist interventions for obesity: improving treatment adherence and patient outcomes. Integr Pharm Res Pract. 2015; 4: 79–89. doi: [10.2147/IPRP.S72206] PMID: 29354522
[11] Canadian Cancer Society’s Advisory Committee on Cancer Statistics. Canadian Cancer Statistics 2015. Toronto (ON): Canadian Cancer Society; 2015.
[12] Lum BL, McWaters DS, Mergener MA. Cancer detection and the community pharmacist. Am Pharm. 1989 Jul; NS29(7):54-9.
[13] Richards MA. The size of the prize for earlier diagnosis of cancer in England. Br J Cancer. 2009 Dec 3; 101 Suppl 2:S125-9.
[14] Havlicek AJ, Mansell H. The community pharmacist’s role in cancer screening and prevention. Can Pharm J (Ott). 2016 Sep; 149(5): 274–282. doi: [10.1177/1715163516660574] PMID: 27708673
[15] Seely JM, Alhassan M. Screening for breast cancer in 2018—what should we be doing today? Curr Oncol. 2018 Jun; 25(Suppl 1): S115–S124. doi: [10.3747/co.25.3770] PMID: 29910654
[16] Calis KA, Hutchison LC, Elliott ME, Ives TJ, Zillich AJ, Poirier T, Raebel MA. Healthy people 2010: challenges, opportunities, and a call to action for America’s pharmacists. Pharmacotherapy. 2004;24(9):1241–1294. doi: 10.1592/phco.24.13.1241.38082.
[17] Naz MSG, Kariman N and others. Educational Interventions for Cervical Cancer Screening Behavior of Women: A Systematic Review. Asian Pac J Cancer Prev. 2018; 19(4): 875–884. doi: [10.22034/APJCP.2018.19.4.875] PMID: 29693331
[18] Lambert P, Bingley PJ. What is Type 1 Diabetes? Medicine 2002;30(1):1‒5 URL:
[19] Jaber LA, Halapy H, Fernet M, Tummalapalli S, Diwakaran H. Evaluation of a pharmaceutical care model on diabetes management. Ann Pharmacother. 1996 Mar; 30(3):238-43.
[20] WHO web. Cardiovascular disease. World Heart Day. Scale up prevention of heart attack and stroke. URL:
[21] WHO web. News/ Fact sheets/Detail/Cardiovascular diseases (CVDs). 17 May 2017
[22] Available From:
[23] Swieczkowski D, Merks P, Gruchala M, et al. The role of the pharmacist in the care of patients with cardiovascular diseases. Kardiol Pol 2016;74:1319–26
[24] Harper-Harrison G, Shanahan MM. Hormone Replacement Therapy. Treasure Island (FL): StatPearls Publishing; 2018 Jan-.
[25] Felty Q. Estrogen-induced DNA synthesis in vascular endothelial cells is mediated by ROS signaling. BMC Cardiovasc. Disord. 2006;6:16 doi: 10.1186/1471-2261-6-16
[26] Chen S.J., Li H., Durand J., Oparil S., Chen Y.F. Estrogen reduces myointimal proliferation after balloon injury of rat carotid artery. Circulation. 1996;93:577–584. doi: 10.1161/01.CIR.93.3.577.
[27] Wilson P.W., Kannel W.B., Silbershatz H., D’Agostino R.B. Clustering of metabolic factors and coronary heart disease. Arch. Intern. Med. 1999;159:1104–1109. doi: 10.1001/archinte.159.10.1104
[28] Ho-Pham L.T., Nguyen N.D., Vu B.Q., Pham H.N., Nguyen T.V. Prevalence and risk factors of radiographic vertebral fracture in postmenopausal Vietnamese women. Bone. 2009;45:213–217. doi: 10.1016/j.bone.2009.04.199
[29] PriorityHealth. CMS/Medicare high-risk medication list. Accessed May 10, 2015.
[30] Tu KN, Lie JD, Wan CKV, et al. Osteoporosis: A Review of Treatment Options. P T. 2018;43(2):92-104.
[31] Jaleel A, Saag KG, Danila MI. Improving drug adherence in osteoporosis: an update on more recent studies. Ther Adv Musculoskelet Dis. 2018;10(7):141-149.
[32] Toh LS, Lai PSM, Othman S, Shah A, Dang CPL, Low BY, Wong KT, Anderson C. Exploring the current and future role of the pharmacists in osteoporosis screening and management in Malaysia. Int J Clin Pharm. 2018 Apr;40(2):450-457. doi: 10.1007/s11096-018-0597-9. Epub 2018 Jan 29. PubMed PMID: 29380234.
[33] Shapiro NL. Chapter 126. Preventive Care. Remington: The Science And Practice Of Pharmacy. Author: Joseph P Remington; Paul Beringer Publisher: Philadelphia: Lippincott Williams & Wilkins, ©2006.
[34] Raybould G, Babatunde O, Evans AL, Jordan JL, Paskins Z. Expressed information needs of patients with osteoporosis and/or fragility fractures: a systematic review. Arch Osteoporos. 2018;13(1):55. Published 2018 May 8. doi:10.1007/s11657-018-0470-4
[35] Balkhi B, Seoane-Vazquez E, Rodriguez-Monguio R. Changes in the utilization of osteoporosis drugs after the 2010 FDA bisphosphonate drug safety communication. Saudi Pharm J. 2017;26(2):238-243.
[36] Deo P, Nayak R, Rajpura J. Women's Attitudes and Health Beliefs toward Osteoporosis Screening in a Community Pharmacy. J Osteoporos. 2013;2013:650136.
[37] Rdzak GM, Whitman LM, Inzucchi SE. Levothyroxine pseudo-malabsorption: testing and treatment in the outpatient setting. Ther Adv Endocrinol Metab. 2018;9(7):217-222.
[38] Bruderer SG, Meier CR, Jick SS, Bodmer M. The association between thyroid disorders and incident gout: population-based case-control study. Clin Epidemiol. 2017;9:205-215. Published 2017 Apr 6. doi:10.2147/CLEP.S128627
[39] Dayan C, Panicker V. Management of hypothyroidism with combination thyroxine (T4) and triiodothyronine (T3) hormone replacement in clinical practice: a review of suggested guidance. Thyroid Res. 2018;11:1. Published 2018 Jan 17. doi:10.1186/s13044-018-0045-x
[40] Patil N, Jialal I. Hypothyroidism. [Updated 2018 Oct 27]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-.
[41] Page MR. New Guidelines for Thyroid Disease Screening: Perspectives for Pharmacists. Pharmacy Times® June 07, 2015.
[42] Bulloch M. Pharmacists Play a Role in Managing Thyroid Conditions. Pharmacy Times® January 31, 2018
[43] Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. Thyroid. 2014;24(12):1670-751.
[44] Terrie YC. A Clinical Care Review for the Pharmacist: Recognizing and Treating Hypothyroidism. Pharmacy Times® November 13, 2012
[45] DeEugenio D. Management of Thyroid Disorders. Pharmacy Times® June 1, 2004.
[46] Freeman G, Pak A, McFadden K, Devi SS. Hypothyroidism. U.S. Pharmacist® September 21, 2009. US Pharm. 2009;34(9):HS-3-HS-6.
[47] Wang J, Wu X, Lai W, et al. Prevalence of depression and depressive symptoms among outpatients: a systematic review and meta-analysis. BMJ Open. 2017;7(8):e017173. Published 2017 Aug 23. doi:10.1136/bmjopen-2017-017173
[48] Bachmann S. Epidemiology of Suicide and the Psychiatric Perspective. Int J Environ Res Public Health. 2018;15(7):1425. Published 2018 Jul 6. doi:10.3390/ijerph15071425
[49] Teter CJ. Counseling Patients Being Treated with Antidepressants. Pharmacy Times® February 01, 2004
[50] Denson BH, Kim RE. Evaluation of provider response to positive depression screenings and physician attitudes on integrating psychiatric pharmacist services in primary care settings. Ment Health Clin. 2018;8(1):28-32. Published 2018 Mar 26. doi:10.9740/mhc.2018.01.028
[51] Guillaumie L, Ndayizigiye A, Beaucage C, et al. Patient perspectives on the role of community pharmacists for antidepressant treatment: A qualitative study. Can Pharm J (Ott). 2018;151(2):142-148. Published 2018 Feb 9. doi:10.1177/1715163518755814
[52] Bostwick JR, Diez HL. Optimizing Care for Patients with Depression in the Community Pharmacy Setting. U.S. Pharmacists November 18, 2008. US Pharm. 2008;33(11):24-28.
[53] Desplenter, F.A., Laekeman, G.M. & Simoens, S.R. Int J Clin Pharm (2011) 33: 101.
[54] Springer S. Self-care counseling for patients with psychiatric disorders. APhA May 1, 2013.
[55] Loew N, Lehan Mackin M, Ayres L. Collegiate Women's Definitions of Responsible Sexual Behavior. West J Nurs Res. 2018 Aug;40(8):1148-1162. doi: 10.1177/0193945917706508. Epub 2017 May 4. PubMed PMID: 28470114; PubMed Central PMCID: PMC5665728.
[56] Miranda PSF, Aquino JMG, Monteiro RMPC, Dixe MDACR, Luz AMBD, Moleiro P. Sexual behaviors: study in the youth. Einstein (Sao Paulo). 2018;16(3):eAO4265. Published 2018 Sep 17. doi:10.1590/S1679-45082018AO4265
[57] Dutta E, Naphade NM. Hypersexuality - a cause of concern: A case report highlighting the need for psychodermatology liaison. Indian J Sex Transm Dis AIDS. 2017;38(2):180-182.
[58] Efrati Y, Gola M. Compulsive sexual behavior: A twelve-step therapeutic approach. J Behav Addict. 2018;7(2):445-453.
[59] Haruna H, Hu X, Chu SKW, Mellecker RR, Gabriel G, Ndekao PS. Improving Sexual Health Education Programs for Adolescent Students through Game-Based Learning and Gamification. Int J Environ Res Public Health. 2018;15(9):2027. Published 2018 Sep 17. doi:10.3390/ijerph15092027
[60] Wood H, Gudka S. Pharmacist-led screening in sexually transmitted infections: current perspectives. Integr Pharm Res Pract. 2018;7:67-82. Published 2018 Jun 15. doi:10.2147/IPRP.S140426
[61] Ross M. 3 STDs Spreading: How Pharmacists Can Help. Pharmacy Times® November 25, 2015
[62] Gilchrist A. How Pharmacists Can Improve STD Treatment Adherence. Pharmacy Times® September 23, 2015
[63] Beresford SE, Crawshaw JP, Bowles SK, Isenor JE. The impact of pharmacists as immunizers in Collaborative cOmmunity Offsite Pharmacy Practice (CO-OPP Phase 1). Can Pharm J (Ott). 2017;151(1):29-32. Published 2017 Nov 29. doi:10.1177/1715163517742163
[64] Alsabbagh MW, Wenger L, Raman-Wilms L, Schneider E, Church D, Waite N. Pharmacists as immunizers, their pharmacies and immunization services: A survey of Ontario community pharmacists. Can Pharm J (Ott). 2018;151(4):263-273. Published 2018 Jun 4. doi:10.1177/1715163518779095
[65] Bluml BM, Brock KA, Hamstra S, Tonrey L. Evaluation of the Impact of an Innovative Immunization Practice Model Designed to Improve Population Health: Results of the Project IMPACT Immunizations Pilot. Popul Health Manag. 2018;21(1):55-62.
[66] Lutz CS, Kim DK, Black CL, Ball SW, Devlin RG, Srivastav A, Fiebelkorn AP, Bridges CB. Clinicians' and Pharmacists' Reported Implementation of Vaccination Practices for Adults. Am J Prev Med. 2018 Sep;55(3):308-318. doi: 10.1016/j.amepre.2018.05.011. Epub 2018 Jul 24. PubMed PMID: 30054198; PubMed Central PMCID: PMC6166242.
[67] O'Reilly DJ, Blackhouse G, Burns S, et al. Economic analysis of pharmacist-administered influenza vaccines in Ontario, Canada. Clinicoecon Outcomes Res. 2018;10:655-663. Published 2018 Oct 24. doi:10.2147/CEOR.S167500
[68] Weitzel KW, Goode JV. Implementation of a pharmacy-based immunization program in a supermarket chain. J Am Pharm Assoc (Wash). 2000 Mar-Apr;40(2):252-6. PubMed PMID: 10730026.
[69] Perman S, Kwiatkowska RM, Gjini A. Do community pharmacists add value to routine immunization programmes? A review of the evidence from the UK. J Public Health (Oxf).2018 Feb 15. doi: 10.1093/pubmed/fdy021. [Epub ahead of print] PubMed PMID: 29462344.
[70] Evans D. Impact of Pharmacy Based Travel Medicine with the Evolution of Pharmacy Practice in the UK. Pharmacy (Basel). 2018;6(3):64. Published 2018 Jul 9. doi:10.3390/pharmacy6030064
[71] Supplements. The Essential Role of Community Pharmacies in Expanding Access to Vaccines. AJMC July 26, 2018
[72] Roszak SE. Reporting to State Immunization Information Systems: Community Pharmacy Perspective. Presentation by Director of Research, NACDS. Available from:
[73] Bach A, Goad J. The role of community pharmacy-based vaccination in the USA: current practice and future directions. Integrated Pharmacy Research and Practice 2015 Volume 2015:4 Pages 67—77.
[74] Meyers R, Weilnau J, Holmes A, Girotto JE, Advocacy Committee on behalf of the Pediatric Pharmacy Advocacy Group. Position Paper: Pharmacists and Childhood Vaccines. J Pediatr Pharmacol Ther. 2018;23(4):343-346.
[75] Thielemier BG. Medical Nutrition Therapy and the Consultant Pharmacist. Pharmapreneur Academy September 17, 2018
[76] McClinchy J, Williams J, Gordon L, Cairns M, Fairey G. Dietary Advice and Collaborative Working: Do Pharmacists and Allied Health Professionals Other Than Dietitians Have a Role?. Healthcare (Basel). 2015;3(1):64-77. Published 2015 Feb 12. doi:10.3390/healthcare3010064
[77] Sacks GS. (2003). Nutrition in Pharmacy Practice. American Journal of Pharmaceutical Education: Volume 67, Issue 2, Article 58.
[78] Mabel Blades, (2000) "Dietary advice to customers of a retail pharmacy store", Nutrition & Food Science, Vol. 30 Issue: 6, pp.310-312,
[79] Terrie YC. Nutritional Supplements and the Role of the Pharmacist. Pharmacy Times® January 01, 2005
[80] Katoue MG, Al-Taweel D. Role of the pharmacist in parenteral nutrition therapy: challenges and opportunities to implement pharmaceutical care in Kuwait. Pharm Pract (Granada). 2016;14(2):680.
[81] Lin HW, Pickard AS, Mahady GB, Karabatsos G, Crawford SY, Popovich NG. An instrument to evaluate pharmacists' patient counseling on herbal and dietary supplements. Am J Pharm Educ. 2010;74(10):192.
[82] Werner SM. Patient safety and the widespread use of herbs and supplements. Front Pharmacol. 2014;5:142. Published 2014 Jun 12. doi:10.3389/fphar.2014.00142
[83] Dwyer JT, Coates PM, Smith MJ. Dietary Supplements: Regulatory Challenges and Research Resources. Nutrients. 2018;10(1):41. Published 2018 Jan 4. doi:10.3390/nu10010041
[84] Jordan SA, Jack SA, Pless RP. Safety Surveillance of Dietary Supplements: Importance, Challenges, and New Horizons. Clin Pharmacol Ther. 2018 Sep;104(3):432-434. doi: 10.1002/cpt.1101. Epub 2018 Aug 16. PubMed PMID: 30117148.
[85] Rizvi RF, Adam TJ, Lindemann EA, et al. Comparing Existing Resources to Represent Dietary Supplements. AMIA Jt Summits Transl Sci Proc. 2018;2017:207-216. Published 2018 May 18.
[86] Maughan RJ, Burke LM, Dvorak J, et al. IOC consensus statement: dietary supplements and the high-performance athlete. Br J Sports Med. 2018;52(7):439-455.
[87] Benatrehina PA, Pan L, Naman CB, Li J, Kinghorn AD. Usage, biological activity, and safety of selected botanical dietary supplements consumed in the United States. J Tradit Complement Med. 2018;8(2):267-277. Published 2018 Mar 2. doi:10.1016/j.jtcme.2018.01.006
[88] Chiba T, Sato Y, Nakanishi T, Yokotani K, Suzuki S, Umegaki K. Inappropriate usage of dietary supplements in patients by miscommunication with physicians in Japan. Nutrients. 2014;6(12):5392-404. Published 2014 Nov 26. doi:10.3390/nu6125392

Key Words:

Pharmacists; Healthcare; Prevention; Care; Risk; Drug; Patient.